secwatch.observer — SEC 8-K summary
======================================

Issuer:     Metagenomi Therapeutics, Inc. (MGX)
CIK:        0001785279
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0000950170-25-084529
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Metagenomi stockholders elect Dr. Willard H. Dere as Class I Director and ratify PwC as auditor
--------------------------------------------------------------------------------

- Dr. Willard H. Dere elected with 7,580,903 votes for, 2,891,893 withheld, and 8,292,425 broker non-votes.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for FY2025: 17,970,776 for, 252,634 against, 541,811 abstentions.
- Annual meeting held June 10, 2025; quorum established with 18,765,221 shares present (50.2% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785279/000095017025084529/0000950170-25-084529-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785279/000095017025084529/mgx-20250610.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-084529

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer